Australia markets open in 24 minutes

Mithra Pharmaceuticals SA (1TM.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.17560.0000 (0.00%)
At close: 08:22AM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
62,675
66,997
22,668
9,030
96,520
Cost of revenue
20,970
19,623
15,724
3,457
2,487
Gross profit
41,705
47,374
6,944
5,573
94,033
Operating expenses
Research development
68,909
64,041
85,243
78,458
57,073
Selling general and administrative
16,940
16,775
14,386
17,367
16,313
Total operating expenses
80,631
73,620
94,820
89,251
67,985
Operating income or loss
-38,926
-26,246
-87,876
-83,678
26,048
Interest expense
20,377
17,002
11,765
3,503
3,321
Income before tax
-33,963
-11,480
-123,769
-110,922
-31,424
Income tax expense
44,878
48,139
-6,895
-18,835
-4,859
Income from continuing operations
-78,842
-59,620
-116,875
-92,086
-26,565
Net income
-78,842
-59,620
-116,875
-92,086
-26,564
Net income available to common shareholders
-78,842
-59,620
-116,875
-92,086
-26,564
Basic EPS
-1.41
-1.22
-2.69
-2.25
-0.70
Diluted EPS
-1.41
-1.22
-2.69
-2.25
-0.70
Basic average shares
55,087
49,059
43,430
40,988
37,752
Diluted average shares
55,087
49,059
43,430
40,988
37,752